Advertisement
Canada markets closed
  • S&P/TSX

    21,969.24
    +83.86 (+0.38%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CAD/USD

    0.7316
    -0.0007 (-0.10%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • Bitcoin CAD

    86,113.08
    -1,824.80 (-2.08%)
     
  • CMC Crypto 200

    1,304.48
    -92.06 (-6.59%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • RUSSELL 2000

    2,002.00
    +20.88 (+1.05%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • NASDAQ

    15,927.90
    +316.14 (+2.03%)
     
  • VOLATILITY

    15.03
    -0.34 (-2.21%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     

3 Canadian Marijuana Stocks to Watch

CORAL GABLES, FL / ACCESSWIRE / September 7, 2018 / The market continues to pay attention to the new highs that companies and industry are seeing. The legalization of cannabis is taking hold on a global scale and even CEO's like Tesla's (TSLA) Elon Musk appear to be taking a liking to new legislation. The fact remains, however that restriction on cannabis persist in places in the U.S., as not all states nor the federal government have made the drug universally legal. Investors are now looking to Canadian marijuana stocks as these have continued to reach new milestones over recent months.

With the industry expecting continued to grow after Oct. 17, when weed will become legal across Canada for any purpose, a number of investors are looking to get a piece of the action. Many of these stocks attracting interest have been of the "five letters" variety; holding the letter "F" at the end of their symbols.

Integrated Cannabis Company (ICNAF) (ICAN) has been in the process of an acquisition for the better part of the last year. Earlier this summer, the company finalized the details and has now successfully acquired all of the issued and outstanding shares of 1127466 B.C. Ltd. ("XSPRAYS"), which holds, through a wholly-owned subsidiary, a worldwide, exclusive license for X-SPRAYSTM - a brand of state-of-the-art life-enhancement products administered via an optimal oral spray delivery system.

Shares of the Canadian cannabis company have been on the rise since the end of August. In a recent shareholder update released this week, the Company stated that it intends to launch an aggressive online marketing campaign to drive sales through the utilization of traditional online channels and via established product influencers. It further stated that it will look to explore potential acquisition opportunities as well.

ADVERTISEMENT

"We are currently in the late stages of reviewing a short list of potential acquisition opportunities that would broaden our product offering from the existing X-SPRAYS™ line to potentially licensed Cannabis formulations in several US States," said Mr. John Knapp, CEO of Integrated Cannabis Company.

For More Information On Integrated Cannabis Company, Click Here

This morning Namaste Technologies Inc (NXTTF) (NV) announced that it has signed a purchase agreement with one of the most popular IPO companies in 2018, Tilray Inc. (TLRY)'s subsidiary Tilray Canada Ltd.

The Company will purchase bulk medical cannabis products from Tilray, to be sold on Namaste's e-commerce platform through its wholly-owned subsidiary Cannmart Inc.

Sean Dollinger, President, and CEO of Namastecomments: "We're very proud to have signed a Purchase Agreement with Tilray, who we believeare one of Canada's leading Licensed Producers. We have already had customers from NamasteMD ordering products through Tilray and the response has been overwhelmingly positive. As such, we are looking forward to offering Tilray's high-quality productsin our platform."

For More Information On Namaste Technologies, Click Here

Further expansion of Canada's legal cannabis industry has also seen companies take measures to address the stance that the US has (or has not) taken on the topic of nationally legal cannabis. Aphria Inc. (APHQF) (APH.TO) announced this week that it has entered into a share purchase agreement with a group of buyers, each acting individually and not in concert and has completed the sale of 64,118,462 shares (in Liberty Health Sciences, Inc. representing 100% of the Company's outstanding investment in Liberty.

In turn, this also represents divestment of all U.S. cannabis assets for Aphria. "Given the current federal legal framework in the United States, we have made the strategic decision to divest our remaining U.S. holdings at this time in order to permit us to focus on other more immediate capital markets and strategic opportunities in Canada and in other legal markets around the world," said Vic Neufeld , Chief Executive Officer of Aphria. "Not only does this transaction result in a significant gain to the Company it also enables Aphria to advance its existing global strategic plan unencumbered by U.S. exposure at this time."

For More Information On Aphria, Inc., Click Here.

About marijuanastocks.com

MarijuanaStocks.com is the leading web destination for all things cannabis. Investors can find marijuana-related financial, medical, legal, and social news anytime day or night. Writers are invited to submit cannabis related articles for publication.

The growing number of clinical trials that are being conducted in immunotherapy is anticipated to fuel the growth of the cancer immunotherapy market. The market is segmented into colorectal cancer, lung cancer, breast cancer, melanoma, prostate cancer, and blood cancer. Based on therapy types, the market can be divided into immune system modulators, immune checkpoint inhibitors, immune checkpoint inhibitors, and monoclonal antibodies. Monoclonal antibodies method has a leading market share, while demand for immune checkpoint inhibitors is expected to increase rapidly.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. MAPH Enterprises LLC which owns www.MarijuanaStocks.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Integrated Cannabis Company, Midam is being paid $25,000 per month for a period of 6 months beginning September 4, 2018, and ending March 9, 2019. We own ZERO shares of Integrated Cannabis Company. We may buy or sell additional shares of (ICNAF)/(ICAN) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Integrated Cannabis Company

Contact Information:

pr@marijuanastocks.com

SOURCE: MarijuanaStocks.com

https://www.accesswire.com/511534/3-Canadian-Marijuana-Stocks-to-Watch